Discovery of 1,4-Substituted Piperidines as Potent and Selective Inhibitors of T-Type Calcium Channels

详细信息    查看全文

• 作者：Zhi-Qiang Yang ; James C. Barrow ; William D. Shipe ; Kelly-Ann S. Schlegel ; Youheng Shu ; F. Vivien Yang ; Craig W. Lindsley ; Kenneth E. Rittle ; Mark G. Bock ; George D. Hartman ; Victor N. Uebele ; Cindy E.
• 刊名：Journal of Medicinal Chemistry
• 出版年：2008
• 出版时间：October 23, 2008
• 年：2008
• 卷：51
• 期：20
• 页码：6471-6477
• 全文大小：192K
• 年卷期：v.51,no.20(October 23, 2008)
• ISSN：1520-4804

文摘

The discovery of a novel series of potent and selective T-type calcium channel antagonists is reported. Initial optimization of high-throughput screening leads afforded a 1,4-substituted piperidine amide 6 with good potency and limited selectivity over hERG and L-type channels and other off-target activities. Further SAR on reducing the basicity of the piperidine and introducing polarity led to the discovery of 3-axial fluoropiperidine 30 with a significantly improved selectivity profile. Compound 30 showed good oral bioavailability and brain penetration across species. In a rat genetic model of absence epilepsy, compound 30 demonstrated a robust reduction in the number and duration of seizures at 33 nM plasma concentration, with no cardiovascular effects at up to 5.6 μM. Compound 30 also showed good efficacy in rodent models of essential tremor and Parkinson’s disease. Compound 30 thus demonstrates a wide margin between CNS and peripheral effects and is a useful tool for probing the effects of T-type calcium channel inhibition.